US2021002666A1PendingUtilityA1

Methods of genetically modifying animal cells

Assignee: WILSON WOLF MFGPriority: Sep 23, 2013Filed: Feb 3, 2020Published: Jan 7, 2021
Est. expirySep 23, 2033(~7.2 yrs left)· nominal 20-yr term from priority
Inventors:John R. Wilson
C12M 23/24C12M 23/08C12N 5/0636C12N 15/63C12N 15/86C12N 2533/00C12N 15/87C12N 15/85C12N 2740/15041
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to improved methods of genetically modifying animal cells by decreasing the distance between cells and genetic modification agents in order to increase the efficiency of genetic modification and/or reduce use of gene modification agents.

Claims

exact text as granted — not AI-modified
1 . A method of culturing and transducing animal cells comprising:
 adding media and animal cells into a device that includes a gas permeable, liquid impermeable growth surface,   wherein at least a portion of said animal cells are T cells that gravitate to said growth surface and said growth surface is in a horizontal position, and   said media is at a first height and said T cells are at a first concentration of T cells per milliliter of media, and   allowing a period of time during which said growth surface is in contact with ambient gas and said T cells increase in quantity thereby creating a second concentration of T cells per milliliter of media, and   reducing the height of the media to a second height in the device to creating a third concentration, of T cells per milliliter of media, and   adding a quantity of genetic modification agents, and   allowing a period of time whereby said genetic modification agents act to transduce at least a portion of said T cells.   
     
     
         2 . The method of  claim 1  wherein, at least a portion of said animal cells that are added into the device are peripheral blood mononuclear cells. 
     
     
         3 . The method of  claim 1  wherein after a portion of said T cells are transduced, media is added to the device, thereby elevating media to a third height, and allowing a period of time during which the transduced T cells increase in quantity. 
     
     
         4 . The method of  claim 1  wherein said animal cells are at a first concentration of 4 million to 20 million cells per milliliter of media. 
     
     
         5 . The method of  claim 1  wherein said animal cells are at a first concentration of 5 million to 20 million cells per milliliter of media. 
     
     
         6 . The method of  claim 1  wherein said animal cells are at a first concentration of 6 million to 20 million cells per milliliter of media. 
     
     
         7 . The method of  claim 1  wherein the media in the device is not in a static state during at least a portion of the period of time whereby said genetic modification agents act to transducer at least a portion of said animal cells. 
     
     
         8 . The method of  claim 1  wherein said genetic modification agent is comprised of lentivirus. 
     
     
         9 . The method of  claim 1  wherein said gas permeable, liquid impermeable material is in contact with a gas permeable material support. 
     
     
         10 . The method of  claim 1  wherein the ratio of the number of genetic modification agents to the quantity of animal cells added to the device is not greater than 2.

Join the waitlist — get patent alerts

Track US2021002666A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.